MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Bid/Ask 15:21:59 23/05/2024 BST | ||
| 1.65 EUR / 1.66 EUR | -0.30% |
|
| Current month | -2.92% | ||
| 1 month | -10.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 1.66 | 0.00% |
| 22/05/24 | 1.66 | +1.22% |
| 21/05/24 | 1.64 | -7.87% |
| 20/05/24 | 1.78 | -2.20% |
| 17/05/24 | 1.82 | +2.82% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 02:22 pm
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MD9808 |
| ISIN | DE000MD98083 |
| Date issued | 10/10/2022 |
| Strike | 32.3 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.1 € |
|---|---|
| Lowest since issue | 0.45 € |
| Spread | 0.01 € |
| Spread % | 0.60% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.16
EUR
Average target price
52.24
EUR
Spread / Average Target
+6.27%
- Stock Market
- Certificates
- Certificat
